Please do not adjust margins
New Journal of Chemistry
Page 7 of 9
DOI: 10.1039/C5NJ03272E
Journal Name
COMMUNICATION
1-phenyl-4-(1-(4-phenylbut-1-yn-1-yl)cyclohexyl)piperazine
115.8, 86.5, 79.6, 58.4, 49.4, 46.0, 35.8, 31.7, 29.6, 29.2, 29.0, 28.8,
(8k): pale yellow solid, mp 78-79 °C. 1H NMR (400 MHz, CDCl3, TMS) 25.6, 22.8, 22.6, 18.6, 14.0; HRMS: exact mass calculated for
δ
7.29-7.23 (m, 5H), 7.21-7.18 (m, 2H), 6.94 (d, J = 7.82 Hz, 2H), C26H41N2 [M + H]+ = 381.3252, found m/z = 381.3270.
6.84 (t, J = 7.33 Hz, 1H), 3.19 (t, J = 5.13 Hz, 4H), 2.83 (t, J = 4.73 Hz,
2H), 2.74 (t, J = 5.13 Hz, 4H), 2.53 (t, J = 7.45 Hz, 2H), 1.93 (m, 2H),
1.66-1.61 (m, 3H), 1.56-1.37 (m, 5H); 13C NMR (100 MHz, CDCl3) δ
151.2, 140.7, 129.0, 128.5, 128.2, 126.0, 119.4, 115.8, 85.4, 80.6,
58.2, 49.4, 45.8, 35.6, 35.5, 25.6, 22.7, 20.7; HRMS: exact mass
calculated for C26H33N2 [M + H]+ = 373.2644, found m/z = 373.2625.
1,4-bis(1-(phenylethynyl)cyclopentyl)piperazine (9c): white
solid, mp 210-212 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.43-7.41
(m, 4H), 7.30-7.26 (m, 6H), 2.79 (s, 8H), 2.13-2.10 (m, 4H), 1.91-1.87
(m, 4H), 1.82-1.72 (m, 8H); 13C NMR (100 MHz, CDCl3) δ 131.7,
128.0, 127.5, 123.6, 91.1, 85.4, 66.7, 49.3, 39.6, 23.3; HRMS: exact
mass calculated for C30H35N2 [M + H]+ = 423.2764, found m/z =
1-(1-(cyclopentylethynyl)cyclohexyl)-4-phenylpiperazine (8l): 423.2764.
white solid, mp 114-116 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.25
(t, J = 8.31 Hz, 2H), 6.94 (d, J = 7.82 Hz, 2H), 6.83 (t, J = 7.33 Hz, 1H),
1-phenyl-4-(1-(phenylethynyl)cyclopentyl)piperazine
(9d):
white solid, mp 143-145 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.42-
7.41 (m, 2H), 7.29-7.24 (m, 5H), 6.95 (d, J = 7.93 Hz, 2H), 6.84 (d, J =
7.32 Hz, 1H), 3.25 (t, J = 5.03, Hz, 4H), 2.88 (t, J = 5.03 Hz, 4H), 2.18-
2.15 (m, 2H), 1.93-1.91 (m, 2H), 1.83-1.77 (m, 4H); 13C NMR (100
MHz, CDCl3) δ 151.2, 131.6, 129.0, 128.1, 127.6, 123.4, 119.5, 115.8,
90.5, 85.6, 66.8, 49.3, 49.1, 39.6, 23.3; HRMS: exact mass calculated
for C23H27N2 [M + H]+ = 331.2174, found m/z = 331.2151.
3.22 (t, J = 5.25 Hz, 4H), 2.79 (t, J = 5.13, Hz, 4H), 2.68-2.61 (m, 1H),
1.97 (m, 2H), 1.90-1.84 (m, 2H), 1.74-1.65 (m, 5H), 1.62-1.52 (m,
7H), 1.42 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 151.2, 129.0, 119.3,
115.7, 91.2, 79.1, 58.2, 49.4, 45.9, 35.8, 34.4, 30.2, 25.7, 24.8, 22.9;
HRMS: exact mass calculated for C23H33N2 [M + H]+ = 337.2644,
found m/z = 337.2622.
1-(1-(hex-1-yn-1-yl)cyclohexyl)-4-phenylpiperazine (8m): pale
yellow solid, mp 101-102 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.25
(t, J = 8.68 Hz, 2H), 6.94 (d, J = 7.94 Hz, 2H), 6.84 (t, J = 7.33 Hz, 1H),
3.22 (t, J = 5.13 Hz, 4H), 2.80 (t, J = 5.13, Hz, 4H), 2.22 (t, J = 7.09 Hz,
2H), 1.97 (d, J = 12.47 Hz, 2H), 1.70-1.67 (m, 2H), 1.59 (m, 3H), 1.52-
1.39 (m, 7H), 0.91 (t, J = 7.21 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ
151.3, 129.0, 119.4, 115.8, 86.3, 79.6, 58.3, 49.4, 45.9, 35.8, 31.3,
25.7, 22.8, 21.9, 18.3, 13.6; HRMS: exact mass calculated for
C22H33N2 [M + H]+ = 325.2644, found m/z = 325.2621.
1-benzyl-4-(1-(phenylethynyl)cyclopentyl)piperazine
(9e):
yellow solid, mp 81-83 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.43-
7.41 (m, 2H), 7.33-7.22 (m, 8H), 3.52 (s, 2H), 2.74 (t, J = 4.83 Hz, 4H),
2.53 (m, 4H), 2.13-2.09 (m, 2H), 1.90-1.86 (m, 2H), 1.82-1.69 (m,
4H); 13C NMR (100 MHz, CDCl3) δ 137.8, 131.6, 129.2, 128.0, 127.6,
126.9, 123.5, 90.9, 85.4, 66.7, 63.0, 53.2, 49.0, 39.6, 23.3; HRMS:
exact mass calculated for C24H29N2 [M + H]+ = 345.2331, found m/z =
345.2309.
1-(1-(hept-1-yn-1-yl)cyclohexyl)-4-phenylpiperazine (8n): Pale
1
N,N-dibutyl-1-(phenylethynyl)cyclopentanamine (9g): yellow
liquid. 1H NMR (400 MHz, CDCl3, TMS) δ 7.40 (d, J = 7.93 Hz, 2H),
7.30-7.23 (m, 3H), 2.61 (t, J = 8.08 Hz, 4H), 2.08 (m, 2H), 1.85-1.76
(m, 6H), 1.53-1.47 (m, 4H), 1.34-1.25 (m, 4H), 0.92 (t, J = 7.32 Hz,
6H); 13C NMR (100 MHz, CDCl3) δ 131.5, 128.1, 127.4, 124.0, 93.6,
83.4, 67.7, 53.0, 40.5, 32.4, 23.1, 20.7, 14.1; HRMS: exact mass
calculated for C21H32N [M + H]+ = 298.2535, found m/z = 298.2511.
yellow solid, mp: 87-89 °C. H NMR (400 MHz, CDCl3, TMS) δ 7.25
(t, J = 8.39 Hz, 2H), 6.94 (d, J = 7.78 Hz, 2H), 6.83 (t, J = 7.32 Hz, 1H),
3.21 (t, J = 5.18 Hz, 4H), 2.80 (t, J = 5.18, Hz, 4H), 2.21 (t, J = 7.17 Hz,
2H), 1.97 (m, 2H), 1.70-1.67 (m, 3H), 1.62-1.57 (m, 3H), 1.54-1.48
(m, 2H), 1.44-1.40 (m, 2H), 1.39-1.35 (m, 2H), 1.34-1.28 (m, 2H),
0.89 (t, J = 7.17 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 151.3, 129.0,
119.4, 115.8, 86.4, 79.7, 58.3, 49.5, 46.0, 35.8, 31.0, 28.9, 25.7,
22.8, 22.1, 18.6, 14.0; HRMS: exact mass calculated for C23H35N2 [M
+ H]+ = 339.2800, found m/z = 339.2777.
Acknowledgements
1-(1-(oct-1-yn-1-yl)cyclohexyl)-4-phenylpiperazine (8o): yellow
solid, mp 82-84 °C. 1H NMR (400 MHz, CDCl3, TMS) δ 7.25 (t, J =
8.80 Hz, 2H), 6.94 (d, J = 7.82 Hz, 2H), 6.83 (t, J = 7.33 Hz, 1H), 3.21
(t, J = 5.13 Hz, 4H), 2.81 (t, J = 5.13, Hz, 4H), 2.21 (t, J = 7.09 Hz, 2H),
1.98 (d, J = 12.34 Hz, 2H), 1.70-1.67 (m, 2H), 1.59 (m, 3H), 1.58-1.36
(m, 7H), 1.33-1.28 (m, 4H), 0.88 (t, J = 6.96 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ 151.3, 129.0, 119.4, 115.8, 86.4, 79.7, 58.3, 49.5,
46.0, 35.8, 31.2, 29.1, 28.5, 25.7, 22.8, 22.5, 18.6, 14.0; HRMS: exact
mass calculated for C24H37N2 [M + H]+ = 353.2957, found m/z =
353.29367.
PCP and KS acknowledge UGC, New Delhi, for providing for
their JRF and Dr. D. S. Kothari postdoctoral research
fellowship.
Notes and references
1
(a) L. Weber, Curr. Med. Chem., 2002, 9, 2085–2093; (b) A.
Jenmalm, W. Berts, Y. L. Li, K. Luthman, I. Csoregh and U.
Hacksell, J. Org. Chem., 1994, 59, 1139–1148; (c) B. M. Trost,
C. K. Chung and A. B. Pinkerton, Angew. Chem., Int. Ed.,
2004, 43, 4327–4329; (d) L. Zani and C. Bolm, Chem.
Commun. 2006, 4263–4275.
1-(1-(dec-1-yn-1-yl)cyclohexyl)-4-phenylpiperazine (8p): yellow
liquid. 1H NMR (400 MHz, CDCl3, TMS) δ 7.25 (t, J = 8.31 Hz, 2H),
6.94 (d, J = 8.92 Hz, 2H), 6.84 (t, J = 7.33 Hz, 1H), 3.22 (t, J = 5.13 Hz,
4H), 2.81 (t, J = 5.13, Hz, 4H), 2.21 (t, J = 6.96 Hz, 2H), 1.98 (m, 2H),
1.70-1.67 (m, 3H), 1.59 (m, 3H), 1.43 (m, 4H), 1.28-1.25 (m, 10H),
0.88 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 151.3, 129.0, 119.4,
2
(a) K. Hattoi, M. Miyata and H. Yamamoto, J. Am. Chem. Soc.,
1993, 115, 1151–1152; (b) M. A. Huffman, N. Yasuda, A. E.
Decamp and E. J. Grabowski, J. Org. Chem., 1995, 60, 1590–
1594; (c) B. Nilsson, H. M. Vargas, B. Ringdahl and U.
Hacksell, J. Med. Chem., 1992, 35, 285–294.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins